HAX is a venture capital program focused on accelerating hardware startups, operating from San Francisco and Shenzhen. Established in 2012, HAX provides founders with essential resources to rapidly prototype and iterate their products, encompassing physical models, technology developments, user interaction studies, and comprehensive business plans. The program supports accepted teams through a combination of full-time staff, mentors, and a vibrant startup community, emphasizing the development of scalable business strategies. Once products are ready for market introduction, teams transition to San Francisco, where HAX assists with business development, fundraising, and establishing critical partnerships. The program includes specialized initiatives such as HAX Growth, a 7-week bootcamp for launching B2C and B2B hardware startups, and HAX Boost, which helps teams refine their sales and marketing strategies while preparing for growth. HAX is part of SOSV, a global venture capital firm with a diverse portfolio, focusing on technology startups that aim to create meaningful innovations.
Flow Neuroscience AB is a healthcare company based in Malmö, Sweden, focused on developing innovative treatment solutions for depression. Established in 2011, the company creates a wearable device that delivers transcranial direct current stimulation (tDCS) to the forehead, targeting the left frontal lobe, an area often associated with reduced activity in individuals suffering from major depressive disorder (MDD). This headset is complemented by a personalized mobile application designed to encourage users to adopt healthier daily routines, such as improved sleep patterns and increased physical activity. By combining brain stimulation with behavioral therapy, Flow Neuroscience aims to provide a medication-free treatment option that is accessible and affordable, challenging the traditional pharmaceutical approaches to depression. The company aspires to make these effective treatments widely available, moving beyond the confines of specialized clinics.
Level Zero Health
Seed Round in 2024
Level Zero Health focuses on advanced biosensor technology to collect new types of data by combining biochemistry and nanotechnology.
Lura Health
Seed Round in 2023
Lura Health has developed a groundbreaking non-invasive health monitoring platform that utilizes saliva as a diagnostic fluid, aiming to enhance clinical outcomes in chronic disease management. Founded in 2017 and based in Cambridge, Massachusetts, the company targets various chronic disease markets, including heart disease, chronic kidney disease, diabetes, and tooth decay. Its innovative sensors are integrated into patient-friendly orthodontic devices such as removable retainers and fixed braces. These sensors continuously measure analytes in saliva and automatically transmit data to a smartphone application, allowing users to track key diagnostic metrics related to their oral health. By enabling individuals to monitor their health in real-time, Lura Health seeks to improve personal health management and empower users to take charge of their well-being.
LightHearted AI
Seed Round in 2023
LightHearted AI is an AI-driven remote cardiovascular diagnostics tool designed for the rapid, precise, and cost-effective detection of heart conditions.
OpenShelf
Seed Round in 2023
OpenShelf, founded in 2023, develops an inventory automation system aimed at optimizing contact lens management for optometrists. The company offers flexible robotic solutions that can handle, sort, and dispense thousands of unique contact lens boxes. This technology allows optometrists to gain valuable insights into their inventory, such as when to reorder specific prescriptions and the frequency of stock replenishment at their practice. By streamlining the contact lens inventory process, OpenShelf enhances operational efficiency and supports better patient care.
DIA
Grant in 2023
Dia has invented an electrochemical sensor that can measure a wide variety of chemical biomarkers non-invasively in saliva or sweat. The data is sent via Bluetooth to an app on the user’s smartphone and analyzed in real-time. From the app, it can be securely sent to a third party. To date, we have measured hormones, electrolytes, neurotransmitters and metabolites. At DIA, we let the biology dictate which analyte we put on which platform – our wearable arm sleeve for sweat or our table-top device for saliva – because some biomarkers, such as cortisol fluctuate throughout the day and need to be monitored through a wearable sensor, while others, such as creatinine are more suitable to a daily saliva test.
Untap Health
Seed Round in 2022
Untap Health has developed a pathogen monitoring platform focused on enhancing community health by detecting infections before they escalate into outbreaks. The platform analyzes wastewater samples from various sources, including commercial sites, schools, and wastewater treatment facilities, to identify viruses present in sewage. By leveraging high-frequency data, Untap provides early warnings of potential health incidents, facilitating timely interventions. This non-invasive and anonymized approach enables communities to maintain cleanliness and safety, effectively contributing to public health monitoring and management.
Bisu
Seed Round in 2022
Bisu is a health technology company that offers a home health lab designed to enhance personal well-being through urine and saliva tests. Its devices monitor various health metrics, including dietary health, fat metabolism, and hydration levels, providing users with daily feedback on electrolytes, hydration, pH, ketones, and uric acid via a mobile application. This functionality enables individuals to track burned body fat, maintain metabolic health, achieve optimal ketosis, and improve physical endurance. Bisu has received recognition for its innovation, having been awarded by prestigious organizations such as Johnson & Johnson Innovation and MedTech Innovator, and it gained further acclaim at CES 2020 with the IHS Markit Innovation Award.
ChronosDx
Seed Round in 2022
ChronosDx is a biotechnology research company based in London, Germany, specializing in drug development and in vitro diagnostics. The firm focuses on creating bioassay technology tailored for diagnostics, drug screening, and development. ChronosDx develops high-performance, cost-effective, and scalable technology that effectively detects various biomarkers, including cell-free DNA, micro proteins, exosomes, and metabolites. This innovative platform enables medical professionals to monitor biomarkers both in-line and in vivo, enhancing the capabilities of healthcare diagnostics.
Kinexcs
Convertible Note in 2022
Kinexcs is an AI-driven health platform and wearables company focused on enhancing mobility and improving quality of life for individuals with musculoskeletal conditions. It addresses issues of incomplete recovery and patient compliance through its innovative digital therapy solutions, which are both cost-effective and convenient. The company has developed KIMIA, the world's first continuous knee health monitor, combined with an AI-based digital therapist that facilitates access to therapy. Kinexcs collaborates with key opinion leaders and major public hospitals in Singapore on various clinical projects, while also offering its products through orthopedic surgeons and significant implant manufacturers. The integration of continuous monitoring and real-time exercise guidance supports patients in managing their conditions effectively.
PONS
Pre Seed Round in 2022
PONS develops artificial intelligence models to enhance ultrasound imaging, unveiling visual insights invisible on conventional devices. Our deep learning algorithms elevate risk assessment of disease progress happening outside the hospital settings and our patented image enhancement system increases basic ultrasound images to provide expert-level scan resolution, tissue contrast, and noise reduction without requiring expensive new hardware. PONS is an AI-integrated machine vision system for mobile ultrasound technologies that lets doctors perform medical imaging remotely. PONS autonomously carries out the risk assessment, smart image processing, segmentation, and reporting of medical images to the doctor. By using PONS, doctors can monitor patients for critical health, women & child health complications anywhere and instantly
Flowbio
Convertible Note in 2022
Flowbio is a wellness and fitness services company that specializes in hydration monitoring for athletes, including triathletes, cyclists, and runners. The firm has developed a real-time hydration biosensor platform that utilizes a wearable, non-invasive patch to analyze sweat and assess key biomarkers, focusing initially on electrolytes and total body fluid loss. This technology enables users to receive personalized recommendations to enhance their athletic performance by better managing their hydration levels.
Portable Diagnostic Systems
Seed Round in 2022
Portable Diagnostic Systems develops a microfluidics-based drug testing platform for law enforcement that takes the guesswork out of impaired driving traffic stops. The company was founded in August 2019.
Zennea Technologies
Convertible Note in 2022
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet wearable designed to address chronic snoring and mild obstructive sleep apnea at its source. Zennea conducts clinical trials to validate the effectiveness of its technology, which not only targets snoring but also tracks sleep quality, assisting users in making informed decisions to enhance their sleep health.
FoodMarble
Convertible Note in 2022
FoodMarble is a company that addresses the challenges faced by nearly one billion individuals with disruptive digestive symptoms. Its flagship product, AIRE, is a personal breath analyzer designed to help users identify which foods are best suited to their unique digestive systems. By utilizing a handheld device and a companion application, AIRE allows individuals to monitor their digestion in real time, leveraging techniques commonly employed in gastroenterology. This innovative approach empowers users to develop personalized diets that can alleviate discomfort and improve their overall well-being. Since its inception, FoodMarble has garnered significant interest, receiving over $500,000 in pre-orders prior to the commencement of device shipments in late 2017. The company aims to create the first comprehensive dataset of its kind, further enhancing users' ability to manage their digestive health.
Harae Dx
Convertible Note in 2022
Harae Dx Corp. is a medical diagnostics company specializing in cancer detection. The company has created an automated, portable system that facilitates early cancer diagnosis by identifying cancer biomarkers directly, eliminating the need to send samples to third-party laboratories. This innovative approach reduces the risk of human error in processing and enhances the speed of results, allowing healthcare professionals to detect and treat cancer more effectively and affordably. Harae Dx's compact and cost-efficient solution aims to improve patient outcomes through timely and accurate diagnostics.
Criam
Seed Round in 2021
Criam is a biotechnology company based in Braga, Portugal, founded in 2015. It specializes in the research and development of a medical device designed for blood type analysis and the detection of infectious diseases. The company's flagship product offers rapid and accurate testing for various conditions, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. This portable device operates independently of electricity or laboratory infrastructure, making it accessible for use in diverse environments. Additionally, Criam's technology is scalable, allowing a single reader to perform multiple tests using specific cartridges and advanced computer vision algorithms. By optimizing blood testing services, Criam aims to provide timely health information and improve clinical decision-making.
Flow Neuroscience
Series A in 2021
Flow Neuroscience AB is a healthcare company based in Malmö, Sweden, focused on developing innovative treatment solutions for depression. Established in 2011, the company creates a wearable device that delivers transcranial direct current stimulation (tDCS) to the forehead, targeting the left frontal lobe, an area often associated with reduced activity in individuals suffering from major depressive disorder (MDD). This headset is complemented by a personalized mobile application designed to encourage users to adopt healthier daily routines, such as improved sleep patterns and increased physical activity. By combining brain stimulation with behavioral therapy, Flow Neuroscience aims to provide a medication-free treatment option that is accessible and affordable, challenging the traditional pharmaceutical approaches to depression. The company aspires to make these effective treatments widely available, moving beyond the confines of specialized clinics.
Neurode
Seed Round in 2021
Neurode is focused on the development of a non-invasive wearable headset aimed at enhancing cognitive performance for individuals with neurological conditions, particularly ADHD. This innovative device employs electrical stimulation to address the imbalances in brain activity commonly associated with ADHD. Alongside the headset, Neurode offers a companion application that monitors users' progress and shares improvements with healthcare professionals. This drug-free approach seeks to alleviate symptoms such as working memory deficits, attention challenges, and impulse control issues, ultimately enabling better management of cognitive performance for users.
Harae Dx
Seed Round in 2021
Harae Dx Corp. is a medical diagnostics company specializing in cancer detection. The company has created an automated, portable system that facilitates early cancer diagnosis by identifying cancer biomarkers directly, eliminating the need to send samples to third-party laboratories. This innovative approach reduces the risk of human error in processing and enhances the speed of results, allowing healthcare professionals to detect and treat cancer more effectively and affordably. Harae Dx's compact and cost-efficient solution aims to improve patient outcomes through timely and accurate diagnostics.
Neurocess
Seed Round in 2021
Neurocess offers services as a wearable technology product that increases the training performance and reduces the risk of injury by analyzing the muscle of professional athletes.
FoodMarble
Seed Round in 2020
FoodMarble is a company that addresses the challenges faced by nearly one billion individuals with disruptive digestive symptoms. Its flagship product, AIRE, is a personal breath analyzer designed to help users identify which foods are best suited to their unique digestive systems. By utilizing a handheld device and a companion application, AIRE allows individuals to monitor their digestion in real time, leveraging techniques commonly employed in gastroenterology. This innovative approach empowers users to develop personalized diets that can alleviate discomfort and improve their overall well-being. Since its inception, FoodMarble has garnered significant interest, receiving over $500,000 in pre-orders prior to the commencement of device shipments in late 2017. The company aims to create the first comprehensive dataset of its kind, further enhancing users' ability to manage their digestive health.
Flow Neuroscience
Convertible Note in 2020
Flow Neuroscience AB is a healthcare company based in Malmö, Sweden, focused on developing innovative treatment solutions for depression. Established in 2011, the company creates a wearable device that delivers transcranial direct current stimulation (tDCS) to the forehead, targeting the left frontal lobe, an area often associated with reduced activity in individuals suffering from major depressive disorder (MDD). This headset is complemented by a personalized mobile application designed to encourage users to adopt healthier daily routines, such as improved sleep patterns and increased physical activity. By combining brain stimulation with behavioral therapy, Flow Neuroscience aims to provide a medication-free treatment option that is accessible and affordable, challenging the traditional pharmaceutical approaches to depression. The company aspires to make these effective treatments widely available, moving beyond the confines of specialized clinics.
Sepsitron
Pre Seed Round in 2020
Sepsitron specializes in medical diagnostic technology that enables the rapid detection of blood infections caused by various pathogens, including viral, bacterial, parasitic, and fungal agents. The company's innovative approach utilizes unique biomarkers, microfluidics, and advanced electronics to provide a diagnostic device that is significantly faster and more cost-effective than traditional methods. Sepsitron's tests require no sample pre-processing and can analyze whole blood samples, allowing for the precise identification of multiple pathogens from a single test. This technology aims to enhance the speed and effectiveness of disease detection and treatment for healthcare professionals. Sepsitron has garnered support from prominent startup accelerators, positioning itself as a leader in point-of-care diagnostics.
Lura Health
Convertible Note in 2020
Lura Health has developed a groundbreaking non-invasive health monitoring platform that utilizes saliva as a diagnostic fluid, aiming to enhance clinical outcomes in chronic disease management. Founded in 2017 and based in Cambridge, Massachusetts, the company targets various chronic disease markets, including heart disease, chronic kidney disease, diabetes, and tooth decay. Its innovative sensors are integrated into patient-friendly orthodontic devices such as removable retainers and fixed braces. These sensors continuously measure analytes in saliva and automatically transmit data to a smartphone application, allowing users to track key diagnostic metrics related to their oral health. By enabling individuals to monitor their health in real-time, Lura Health seeks to improve personal health management and empower users to take charge of their well-being.
Zennea Technologies
Seed Round in 2020
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet wearable designed to address chronic snoring and mild obstructive sleep apnea at its source. Zennea conducts clinical trials to validate the effectiveness of its technology, which not only targets snoring but also tracks sleep quality, assisting users in making informed decisions to enhance their sleep health.
Vigilant Technologies
Convertible Note in 2019
VIT is a health and safety company that is using smart technology to create products that help you better understand your body. By focusing on the patterns and behaviors that cause problematic behavior, their products can help identify the root cause of health problems before complications occur.
Sepsitron
Pre Seed Round in 2019
Sepsitron specializes in medical diagnostic technology that enables the rapid detection of blood infections caused by various pathogens, including viral, bacterial, parasitic, and fungal agents. The company's innovative approach utilizes unique biomarkers, microfluidics, and advanced electronics to provide a diagnostic device that is significantly faster and more cost-effective than traditional methods. Sepsitron's tests require no sample pre-processing and can analyze whole blood samples, allowing for the precise identification of multiple pathogens from a single test. This technology aims to enhance the speed and effectiveness of disease detection and treatment for healthcare professionals. Sepsitron has garnered support from prominent startup accelerators, positioning itself as a leader in point-of-care diagnostics.
FoodMarble
Convertible Note in 2019
FoodMarble is a company that addresses the challenges faced by nearly one billion individuals with disruptive digestive symptoms. Its flagship product, AIRE, is a personal breath analyzer designed to help users identify which foods are best suited to their unique digestive systems. By utilizing a handheld device and a companion application, AIRE allows individuals to monitor their digestion in real time, leveraging techniques commonly employed in gastroenterology. This innovative approach empowers users to develop personalized diets that can alleviate discomfort and improve their overall well-being. Since its inception, FoodMarble has garnered significant interest, receiving over $500,000 in pre-orders prior to the commencement of device shipments in late 2017. The company aims to create the first comprehensive dataset of its kind, further enhancing users' ability to manage their digestive health.
UCHU Biosensors
Seed Round in 2019
UCHU Biosensors develops a platform of tooth mounted sensors to effortlessly track health through saliva.
Seein Health
Venture Round in 2019
Seein Health is a developer of pro-pregnancy products focused on enhancing fertility and supporting maternal health. The company offers a range of products, including thermometers, menstrual test strips, and advanced physiological parameter monitoring equipment. These products aim to ensure the health and safety of pregnant mothers by providing essential tools for monitoring fertility and pregnancy status. Additionally, Seein Health provides overseas services related to test-tube baby procedures and frozen eggs, further contributing to reproductive health solutions.
Kinexcs
Seed Round in 2019
Kinexcs is an AI-driven health platform and wearables company focused on enhancing mobility and improving quality of life for individuals with musculoskeletal conditions. It addresses issues of incomplete recovery and patient compliance through its innovative digital therapy solutions, which are both cost-effective and convenient. The company has developed KIMIA, the world's first continuous knee health monitor, combined with an AI-based digital therapist that facilitates access to therapy. Kinexcs collaborates with key opinion leaders and major public hospitals in Singapore on various clinical projects, while also offering its products through orthopedic surgeons and significant implant manufacturers. The integration of continuous monitoring and real-time exercise guidance supports patients in managing their conditions effectively.
Bravrr
Pre Seed Round in 2019
Bravrr, LLC is a company based in Canon City, Colorado, specializing in the development of wearable diagnostic and therapeutic tools. Founded in 2019, Bravrr's flagship product, BruxRelief, is a smart biofeedback wearable designed to detect, treat, and eliminate bruxism disorder, which affects approximately one in three individuals, yet remains largely undiagnosed. The BruxRelief headband utilizes advanced sensors and artificial intelligence to monitor clenching and grinding behaviors in the temporalis muscle, allowing users to identify stress triggers associated with these actions. The device connects to a smartphone app that analyzes users' bruxism behavior and sleep patterns, providing an accessible solution in a market where existing diagnostic tools are often overly complex and expensive. By offering a simple, effective means to address bruxism, Bravrr aims to improve the quality of life for those suffering from this painful condition.
Vision Infinitas
Seed Round in 2019
Vision Infinitas is a company that specializes in wearable sensor technology designed to monitor and optimize personal energy levels. The device automatically tracks an individual's dietary intake, including everything consumed as food and drink, to provide insights into nourishment and energy management. Currently, Vision Infinitas is operating in stealth mode, focusing on refining its product and developing its market strategy.
Bisu
Convertible Note in 2019
Bisu is a health technology company that offers a home health lab designed to enhance personal well-being through urine and saliva tests. Its devices monitor various health metrics, including dietary health, fat metabolism, and hydration levels, providing users with daily feedback on electrolytes, hydration, pH, ketones, and uric acid via a mobile application. This functionality enables individuals to track burned body fat, maintain metabolic health, achieve optimal ketosis, and improve physical endurance. Bisu has received recognition for its innovation, having been awarded by prestigious organizations such as Johnson & Johnson Innovation and MedTech Innovator, and it gained further acclaim at CES 2020 with the IHS Markit Innovation Award.
Zennea Technologies
Convertible Note in 2019
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet wearable designed to address chronic snoring and mild obstructive sleep apnea at its source. Zennea conducts clinical trials to validate the effectiveness of its technology, which not only targets snoring but also tracks sleep quality, assisting users in making informed decisions to enhance their sleep health.
Lura Health
Seed Round in 2019
Lura Health has developed a groundbreaking non-invasive health monitoring platform that utilizes saliva as a diagnostic fluid, aiming to enhance clinical outcomes in chronic disease management. Founded in 2017 and based in Cambridge, Massachusetts, the company targets various chronic disease markets, including heart disease, chronic kidney disease, diabetes, and tooth decay. Its innovative sensors are integrated into patient-friendly orthodontic devices such as removable retainers and fixed braces. These sensors continuously measure analytes in saliva and automatically transmit data to a smartphone application, allowing users to track key diagnostic metrics related to their oral health. By enabling individuals to monitor their health in real-time, Lura Health seeks to improve personal health management and empower users to take charge of their well-being.
Kinexcs
Seed Round in 2018
Kinexcs is an AI-driven health platform and wearables company focused on enhancing mobility and improving quality of life for individuals with musculoskeletal conditions. It addresses issues of incomplete recovery and patient compliance through its innovative digital therapy solutions, which are both cost-effective and convenient. The company has developed KIMIA, the world's first continuous knee health monitor, combined with an AI-based digital therapist that facilitates access to therapy. Kinexcs collaborates with key opinion leaders and major public hospitals in Singapore on various clinical projects, while also offering its products through orthopedic surgeons and significant implant manufacturers. The integration of continuous monitoring and real-time exercise guidance supports patients in managing their conditions effectively.
Seein Health
Seed Round in 2018
Seein Health is a developer of pro-pregnancy products focused on enhancing fertility and supporting maternal health. The company offers a range of products, including thermometers, menstrual test strips, and advanced physiological parameter monitoring equipment. These products aim to ensure the health and safety of pregnant mothers by providing essential tools for monitoring fertility and pregnancy status. Additionally, Seein Health provides overseas services related to test-tube baby procedures and frozen eggs, further contributing to reproductive health solutions.
ZiO Health
Seed Round in 2018
ZiO Health is a biotechnology company that focuses on transforming laboratory testing through its proprietary pocket-sized technology, which allows for point-of-care diagnostics. By combining advanced biosensor technology with machine learning algorithms, ZiO Health provides real-time testing results tailored to each patient's unique profile. This innovative approach enables users to measure, test, and detect the molecular composition of various substances, facilitating personalized health insights. The company's devices aim to optimize health management and enhance patient outcomes, allowing individuals to conduct quality home diagnostics and take proactive steps in preventing illness.
Hisens
Seed Round in 2018
Hisens is a company focused on developing an innovative underwearable sensor designed to monitor erectile dysfunction. The product includes a mobile application that works in conjunction with wearable sensors to collect physiological data from users in real time while they sleep. This technology allows for professional data analysis and personalized treatment options. By enabling users to track their own data, treatment progress, rehabilitation degrees, and the effectiveness of various treatment options, Hisens facilitates better communication between patients and their healthcare providers.
FoodMarble
Seed Round in 2018
FoodMarble is a company that addresses the challenges faced by nearly one billion individuals with disruptive digestive symptoms. Its flagship product, AIRE, is a personal breath analyzer designed to help users identify which foods are best suited to their unique digestive systems. By utilizing a handheld device and a companion application, AIRE allows individuals to monitor their digestion in real time, leveraging techniques commonly employed in gastroenterology. This innovative approach empowers users to develop personalized diets that can alleviate discomfort and improve their overall well-being. Since its inception, FoodMarble has garnered significant interest, receiving over $500,000 in pre-orders prior to the commencement of device shipments in late 2017. The company aims to create the first comprehensive dataset of its kind, further enhancing users' ability to manage their digestive health.
Metabolomic Diagnostics
Seed Round in 2018
Metabolomic Diagnostics Ltd. is a medical diagnostics company based in Little Island, Ireland, founded in 2011. The company specializes in developing advanced diagnostic solutions that utilize mass spectrometry technology to analyze biomarkers associated with complex diseases. Its primary focus is on providing predictive diagnoses for pre-eclampsia in early pregnancy through a blood test that assesses the risk of this condition, which can lead to serious complications such as hypertension and restricted blood flow to the fetus. Metabolomic Diagnostics has established a pipeline for identifying diagnostic biomarker panels and translating these findings into clinical assays suitable for use in laboratory settings, thus enabling effective disease diagnosis and risk prediction.
HabitAware
Seed Round in 2018
HabitAware manufactures and distributes wearable devices that assists its users with minimizing trichotillomania. The devices use motion sensors to assist its users with minimizing repetitive habits, including nail biting, hair pulling, skin picking, and thumb sucking by providing it with training. It features Bluetooth connectivity and customizable vibration patterns. HabitAware was founded in 2014 and is based in Minneapolis.
Zennea Technologies
Pre Seed Round in 2018
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet wearable designed to address chronic snoring and mild obstructive sleep apnea at its source. Zennea conducts clinical trials to validate the effectiveness of its technology, which not only targets snoring but also tracks sleep quality, assisting users in making informed decisions to enhance their sleep health.
Flow Neuroscience
Seed Round in 2018
Flow Neuroscience AB is a healthcare company based in Malmö, Sweden, focused on developing innovative treatment solutions for depression. Established in 2011, the company creates a wearable device that delivers transcranial direct current stimulation (tDCS) to the forehead, targeting the left frontal lobe, an area often associated with reduced activity in individuals suffering from major depressive disorder (MDD). This headset is complemented by a personalized mobile application designed to encourage users to adopt healthier daily routines, such as improved sleep patterns and increased physical activity. By combining brain stimulation with behavioral therapy, Flow Neuroscience aims to provide a medication-free treatment option that is accessible and affordable, challenging the traditional pharmaceutical approaches to depression. The company aspires to make these effective treatments widely available, moving beyond the confines of specialized clinics.
Criam
Convertible Note in 2018
Criam is a biotechnology company based in Braga, Portugal, founded in 2015. It specializes in the research and development of a medical device designed for blood type analysis and the detection of infectious diseases. The company's flagship product offers rapid and accurate testing for various conditions, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. This portable device operates independently of electricity or laboratory infrastructure, making it accessible for use in diverse environments. Additionally, Criam's technology is scalable, allowing a single reader to perform multiple tests using specific cartridges and advanced computer vision algorithms. By optimizing blood testing services, Criam aims to provide timely health information and improve clinical decision-making.
Pillsy
Seed Round in 2017
Pillsy is an enterprise-grade platform for remote patient support and rapid development of connected medication experiences. It is a new smart pill bottle and app that uses behavioral science to support healthy habits around vitamins and medications. It also securely share the pill-taking information with loved ones and to help monitor people. Pillsy was founded in 2015 and is headquartered in Seattle, Washington.
AptaCam
Pre Seed Round in 2017
AptaCam is a biotechnology company based in Shenzhen, China, that specializes in the development of biosensors for the detection of human papillomavirus (HPV) and other infectious diseases. Founded in 2014, the company also creates software that enhances the functionality of its portable diagnostic devices by enabling data analysis and collection when connected to a computer. AptaCam aims to be a leading producer of high-quality aptamers, which are short, single-stranded molecules that can be tailored for high specificity to various targets. The company's innovative platform supports clinical diagnostics, drug discovery, and monitoring in medical, environmental, and food safety applications. Through its commitment to simplifying molecular recognition, AptaCam provides comprehensive aptamer solutions across diverse disciplines.
Kinexcs
Pre Seed Round in 2017
Kinexcs is an AI-driven health platform and wearables company focused on enhancing mobility and improving quality of life for individuals with musculoskeletal conditions. It addresses issues of incomplete recovery and patient compliance through its innovative digital therapy solutions, which are both cost-effective and convenient. The company has developed KIMIA, the world's first continuous knee health monitor, combined with an AI-based digital therapist that facilitates access to therapy. Kinexcs collaborates with key opinion leaders and major public hospitals in Singapore on various clinical projects, while also offering its products through orthopedic surgeons and significant implant manufacturers. The integration of continuous monitoring and real-time exercise guidance supports patients in managing their conditions effectively.
Bisu
Pre Seed Round in 2017
Bisu is a health technology company that offers a home health lab designed to enhance personal well-being through urine and saliva tests. Its devices monitor various health metrics, including dietary health, fat metabolism, and hydration levels, providing users with daily feedback on electrolytes, hydration, pH, ketones, and uric acid via a mobile application. This functionality enables individuals to track burned body fat, maintain metabolic health, achieve optimal ketosis, and improve physical endurance. Bisu has received recognition for its innovation, having been awarded by prestigious organizations such as Johnson & Johnson Innovation and MedTech Innovator, and it gained further acclaim at CES 2020 with the IHS Markit Innovation Award.
ZiO Health
Convertible Note in 2017
ZiO Health is a biotechnology company that focuses on transforming laboratory testing through its proprietary pocket-sized technology, which allows for point-of-care diagnostics. By combining advanced biosensor technology with machine learning algorithms, ZiO Health provides real-time testing results tailored to each patient's unique profile. This innovative approach enables users to measure, test, and detect the molecular composition of various substances, facilitating personalized health insights. The company's devices aim to optimize health management and enhance patient outcomes, allowing individuals to conduct quality home diagnostics and take proactive steps in preventing illness.
Digi.Bio
Seed Round in 2017
Digi.Bio is a Netherlands-based company that specializes in developing software solutions for the healthcare industry, particularly in the field of cell therapies. It offers a microfluidic platform that automates repetitive and manual laboratory workflows, utilizing artificial intelligence and electrowetting technology to manipulate droplets at a microscale. This innovative approach aims to streamline multistep liquid handling applications, replacing traditional pipetting methods. Digi.Bio's platform delivers comprehensive analysis of cell therapies, evaluating their performance and outcomes at the single-cell level within 24 hours, while minimizing material waste. By enhancing automation in medical and pharmaceutical settings, Digi.Bio supports the advancement of bioengineering processes.
Mojo
Pre Seed Round in 2017
For everyone who wants to expand their family-building potential, Mojo offers an online fertility care platform helping humans to test, understand and improve their fertility. Unlike current fertility care systems, which are only accessible by the privileged few at high costs and inferior effectiveness, the Mojo platform is accessible to everyone and powered by AI to ensure an unmatched level of effectiveness, scientific standard, and convenience at remarkable pricing.
Hisens
Convertible Note in 2016
Hisens is a company focused on developing an innovative underwearable sensor designed to monitor erectile dysfunction. The product includes a mobile application that works in conjunction with wearable sensors to collect physiological data from users in real time while they sleep. This technology allows for professional data analysis and personalized treatment options. By enabling users to track their own data, treatment progress, rehabilitation degrees, and the effectiveness of various treatment options, Hisens facilitates better communication between patients and their healthcare providers.
Criam
Convertible Note in 2016
Criam is a biotechnology company based in Braga, Portugal, founded in 2015. It specializes in the research and development of a medical device designed for blood type analysis and the detection of infectious diseases. The company's flagship product offers rapid and accurate testing for various conditions, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. This portable device operates independently of electricity or laboratory infrastructure, making it accessible for use in diverse environments. Additionally, Criam's technology is scalable, allowing a single reader to perform multiple tests using specific cartridges and advanced computer vision algorithms. By optimizing blood testing services, Criam aims to provide timely health information and improve clinical decision-making.
Criam
Seed Round in 2016
Criam is a biotechnology company based in Braga, Portugal, founded in 2015. It specializes in the research and development of a medical device designed for blood type analysis and the detection of infectious diseases. The company's flagship product offers rapid and accurate testing for various conditions, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. This portable device operates independently of electricity or laboratory infrastructure, making it accessible for use in diverse environments. Additionally, Criam's technology is scalable, allowing a single reader to perform multiple tests using specific cartridges and advanced computer vision algorithms. By optimizing blood testing services, Criam aims to provide timely health information and improve clinical decision-making.
Hisens
Seed Round in 2016
Hisens is a company focused on developing an innovative underwearable sensor designed to monitor erectile dysfunction. The product includes a mobile application that works in conjunction with wearable sensors to collect physiological data from users in real time while they sleep. This technology allows for professional data analysis and personalized treatment options. By enabling users to track their own data, treatment progress, rehabilitation degrees, and the effectiveness of various treatment options, Hisens facilitates better communication between patients and their healthcare providers.
my.Flow
Convertible Note in 2016
Here at my.Flow, They are determined to find a fix that will help you get to know yourself and your flow, empowering women through insight and changing the outdated nature of current menstrual solutions and the general hush surrounding menstruation. They have a works-like and looks-like Patent Pending model ready to launch!
HabitAware
Convertible Note in 2016
HabitAware manufactures and distributes wearable devices that assists its users with minimizing trichotillomania. The devices use motion sensors to assist its users with minimizing repetitive habits, including nail biting, hair pulling, skin picking, and thumb sucking by providing it with training. It features Bluetooth connectivity and customizable vibration patterns. HabitAware was founded in 2014 and is based in Minneapolis.
FoodMarble
Convertible Note in 2016
FoodMarble is a company that addresses the challenges faced by nearly one billion individuals with disruptive digestive symptoms. Its flagship product, AIRE, is a personal breath analyzer designed to help users identify which foods are best suited to their unique digestive systems. By utilizing a handheld device and a companion application, AIRE allows individuals to monitor their digestion in real time, leveraging techniques commonly employed in gastroenterology. This innovative approach empowers users to develop personalized diets that can alleviate discomfort and improve their overall well-being. Since its inception, FoodMarble has garnered significant interest, receiving over $500,000 in pre-orders prior to the commencement of device shipments in late 2017. The company aims to create the first comprehensive dataset of its kind, further enhancing users' ability to manage their digestive health.
my.Flow
Pre Seed Round in 2016
Here at my.Flow, They are determined to find a fix that will help you get to know yourself and your flow, empowering women through insight and changing the outdated nature of current menstrual solutions and the general hush surrounding menstruation. They have a works-like and looks-like Patent Pending model ready to launch!
Berkeley Ultrasound
Convertible Note in 2015
Since 2014 Berkeley Ultrasound company has sought to enable frictionless access to Ultrasound as a brain stimulation tool. fTUS is available for investigative use and non-clinical applications.
Berkeley Ultrasound
Seed Round in 2015
Since 2014 Berkeley Ultrasound company has sought to enable frictionless access to Ultrasound as a brain stimulation tool. fTUS is available for investigative use and non-clinical applications.
FeetMe
Seed Round in 2015
FeetMe is a digital health company specializing in advanced technology for gait and activity assessments in both clinical and real-world settings. The company develops innovative wearable products, particularly smart insoles equipped with pressure sensors and motion analysis algorithms. These products enable real-time monitoring of patients' mobility and posture, facilitating comprehensive evaluations of movement disorders and mobility constraints. By providing relevant digital biomarkers, FeetMe aims to support clinical research and enhance patient care, allowing healthcare professionals to track disease progression, improve functional outcomes, and optimize treatment strategies.
Ninu
Seed Round in 2015
Ninu is a free app that provides information about the entire nine months of pregnancy and tips on health, nutrition, and baby’s development stages. It offers personalized pregnancy information for mothers-to-be, their partners, and doctors. Wearable sensors collect data such as baby movements, pains, baby kicks, stress level, and sleep patterns to provide insights on issues like preterm birth risks, pains, and lifestyle. Visualized data enables pregnant mothers to objectively discuss symptoms with doctors and the Ninu community. Ninu is operated from Munich, Germany.
BBB
Seed Round in 2015
BBB Tech, based in Silicon Valley, is a mobile healthcare technology startup that focuses on providing accessible medical services. The company has developed "Elemark," an Android-powered mobile blood diagnostic device capable of testing for over 50 medical conditions in a matter of seconds using just one drop of blood. This innovative device is part of an integrated service platform that leverages artificial intelligence to analyze blood biomarkers, facilitating early detection of cancer and severe disorders. By enabling patients to conduct regular tests from the comfort of their homes, BBB Tech allows for effective remote monitoring of health markers by physicians, thus promoting timely medical intervention and enhancing overall health management. Established in 2014, BBB Tech has received recognition in various startup competitions, highlighting its commitment to revolutionizing the healthcare landscape.
Lief Therapeutics
Seed Round in 2015
Lief Therapeutics is a medical device company focused on improving at-home care for individuals suffering from post-traumatic stress disorder, depression, and anxiety. The company has developed a discreet biosensing patch that measures heart rate and breathing patterns with medical accuracy. This wearable device, known as Lief, helps users manage their stress responses through biofeedback exercises, allowing them to monitor their emotions and behaviors in real-time. Additionally, the device provides clinicians with insights into patient progress, enabling in-session training and tracking of psychological assessments. Lief Therapeutics also offers the Lief Health Score application, which records thoughts, emotions, and sensations, facilitating the tracking of daily progress and personalized practice exercises. Founded in 2014 and based in San Francisco, California, the company sells its products online.
Darma
Pre Seed Round in 2014
Darma Inc. specializes in non-wearable health tracking technology, offering a unique DARMA cushion that allows users to monitor their vital signs through a dedicated application. This innovative cushion tracks stress levels, sitting time, and posture, providing reminders to encourage users to stand and move. Additionally, it alerts users to high stress levels and suggests guided meditation for stress management. Beyond the DARMA cushion, the company has developed a 2mm fiber optic sensor pad designed for placement under mattresses in hospitals or homes, enabling continuous and non-invasive monitoring of vital signs and cardiac performance. This integrated system aims to enhance proactive health management, reduce hospital readmissions, and improve the quality of life for patients with chronic diseases by utilizing advanced algorithms and machine learning to predict and prevent adverse health events.
Notch
Pre Seed Round in 2013
Personal trainer powered by wearable technology and fitness experts & celebrities that guides you through workouts with live audio feedback. Train with Notch to get real-time guidance and motivation on your form, reps, and amount of weights.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.